Bulletin Comes in Wake of Recent Attacks Disrupting Blood Collection, Supplies
The Food and Drug Administration is urging blood suppliers to bolster their cybersecurity practices to prevent and mitigate cyber incidents that could affect the supply and safety of critical blood and blood components used for transfusions and other patient care.
“The trio of ransomware attacks starting in April 2024 on OneBlood, Synnovis, and Octapharma Plasma by Russian cybercrime ransomware gangs caused disruption to blood and plasma supplies in regions across the U.S. and U.K., ultimately causing major impacts to patient care,” said Errol Weiss, chief security officer at Health-ISAC.
Read the full article in Healthcare Infosecurity Click Here
As Health-ISAC and AHA warned in August, the attacks on those three critical third-party suppliers significantly affected healthcare delivery, Weiss said. “It should serve as a wake-up call across the industry to address supply chain resilience. It’s not just about ensuring IT systems are secure, but also making sure critical hospital operations can continue to function in the face of widespread IT system outages,” Weiss said.
